Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for ...

This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication ...

About FIRDAPSE ® (amifampridine) Tablets 10 mg FIRDAPSE ® (amifampridine) Tablets 10 mg is an oral, nonspecific, voltage-dependent, potassium (K+) channel blocker that causes depolarization of ...

announced that it has entered into a settlement agreement with Teva Pharmaceuticals TEVA regarding the Firdapse (amifampridine) patent litigation. The settlement agreement resolves the patent ...

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...